12:00 AM
 | 
Jun 20, 2013
 |  BC Innovations  |  Distillery Therapeutics

Indication: Pulmonary disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information
Pulmonary disease
Pulmonary disease Mucin 5B oligomeric mucus/gel-forming (MUC5B)...

Read the full 163 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >